Truly moving the needle in clinical trial diversity comes down to embracing two fundamental pieces of the DE&I puzzle.
Pamela Tenaerts, MD
Advertisement
Chief Scientific Officer, Medable
Articles by Pamela Tenaerts, MD
New recommendations offer guidance on overcoming legal, regulatory, and practical hurdles.
Advertisement
Latest Updated Articles
- Overcoming Barriers in Conducting Decentralized Clinical Trials
Published: February 4th 2020 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
Accelerating Site Payments with Agentic AI: See it in Action
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
